Skip to main content
SpringerLink
Log in

Physiopathology, Diagnosis, and Treatment of Secondary Hyperthyroidism

  • Reference work entry
  • First Online:
Hypothalamic-Pituitary Diseases

Part of the book series: Endocrinology ((ENDOCR))

Abstract

Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare cause of secondary hyperthyroidism and account for less than 2% of all pituitary adenomas. In the last 30 years, the recognition of TSHomas has been facilitated by the routine use of ultrasensitive TSH immunometric assays, i.e., methods clearly able to distinguish between TSH concentration in normal controls and undetectable TSH levels in hyperthyroid patients, as well as by the direct measurement of circulating free thyroid hormones (FT4 and FT3). TSHomas must be promptly diagnosed whenever measurable levels of TSH in the presence of high FT4 and FT3 concentrations are documented. As similar biochemical picture is found in patients with thyroid hormone resistance (RTH), a differential diagnosis between the two disorders must be performed. Therefore, a correct diagnosis is fundamental in order to prevent dramatic consequences, such as improper thyroidectomy in patients with secondary hyperthyroidism due to TSHoma or unnecessary pituitary surgery in patients with RTH. The differential diagnosis between TSHomas and RTH mainly rests on dynamic testing, such as T3 suppression test, TRH tests, as well as injection of long acting somatostatin for 2 or more months.

First-line therapeutical approach to TSHomas remains pituitary neurosurgery, though in particular cases medical treatment should be considered. The medical treatment of TSHomas mainly rests on the administration of somatostatin analogs, such as octreotide and lanreotide, which are effective in reducing TSH secretion in the majority of patients with consequent normalization of FT4 and FT3 levels and restoration of the euthyroid state.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abs R, Stevenaert A, Beckers A. Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol. 1994;131:355–8.

    Article  CAS  PubMed  Google Scholar 

  • Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol. 2001a;15:1529–38.

    Article  CAS  PubMed  Google Scholar 

  • Ando S, Sarlis NJ, Oldfield EH, Yen PM. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab. 2001b;86: 5572–6.

    CAS  PubMed  Google Scholar 

  • Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab. 1993;77:1275–80.

    CAS  PubMed  Google Scholar 

  • Asteria C, Anagni M, Persani L, Beck-Peccoz P. Loss of heterozigosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas. J Endocrinol Investig. 2001;24:796–801.

    Article  CAS  Google Scholar 

  • Azzalin A, Appin CL, Schniederjan MJ, Constantin T, Ritchie JC, Veledar E, Oyesiku NM, Ioachimescu AG. Comprehensive evaluation of thyrotropinomas: single-center 20-year experience. Pituitary. 2016;19:183–93.

    Article  PubMed  Google Scholar 

  • Banerjee AK, Sharma BS, Kak VK. Clinically and biochemically silent thyrotroph adenoma with oncocytic change. Neurol India. 2000;48:374–7.

    CAS  PubMed  Google Scholar 

  • Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab. 2007;92:1952–5.

    Article  CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Persani L. Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol. 1994;131:331–40.

    Article  CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Mariotti S, Guillausseau PJ, Medri G, Piscitelli G, Bertoli A, Barbarino Rondena AM, Chanson P, Pinchera A. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 1989;68:208–14.

    Article  CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, Forloni F, Pinchera A, Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab. 1990;71:19–25.

    Article  CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Persani L, Faglia G. Glycoprotein hormone alpha-subunit in pituitary adenomas. Trends Endocrinol Metab. 1992;3:41–5.

    Article  CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev. 1996;17:610–38.

    CAS  PubMed  Google Scholar 

  • Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL. European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J. 2013;2:76–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Beck-Peccoz P, Lania A, Persani L. TSH-producing adenomas. In: Jameson JL, DeGroot LJ, editors. Endocrinology adult and pediatric. 7th ed. Philadelphia: Elsevier Saundres; 2016. p. 266–74.

    Chapter  Google Scholar 

  • Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab. 1992;75:540–6.

    CAS  PubMed  Google Scholar 

  • Bertholon-Grégoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J. Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol. 1999;140:519–27.

    Article  PubMed  Google Scholar 

  • Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol. 2002;57:401–4.

    Article  CAS  Google Scholar 

  • Brown RL, Muzzafar T, Wollman R, Weiss RE. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol. 2006;154:639–43.

    Article  CAS  PubMed  Google Scholar 

  • Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub B. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab. 1999;84: 476–86.

    Article  CAS  PubMed  Google Scholar 

  • Chaiamnuay S, Moster M, Katz MR, Kim YN. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary. 2003;6:109–13.

    Article  PubMed  Google Scholar 

  • Chanson P, Orgiazzi J, Derome PJ, Bression D, Jedynak CP, Trouillas J, Legentil P, Racadot J, Peillon F. Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab. 1984;59:542–6.

    Article  CAS  PubMed  Google Scholar 

  • Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med. 1993;119:236–40.

    Article  CAS  PubMed  Google Scholar 

  • Clarke MJ, Erickson D, Castro MR, Atkinson JLD. Thyroid-stimulating pituitary adenomas. J Neurosurg. 2008;109:17–22.

    Article  PubMed  Google Scholar 

  • Cohen LE, Radovick S. Molecular bases of pituitary hormone deficiencies. Endocr Rev. 2002;23:431–42.

    Article  CAS  PubMed  Google Scholar 

  • Collie RB, Collie MJ. Extracranial thyroid-stimulating hormone-secreting ectopic pituitary adenoma of the nasopharynx. Otolaryngol Head Neck Surg. 2005;133:453–4.

    Article  PubMed  Google Scholar 

  • Cooper DS, Wenig BM. Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor. Thyroid. 1996;6:337–43.

    Article  CAS  PubMed  Google Scholar 

  • Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás AF, Labarta Aizpún JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein MT, Vanbellinghen JF, Barra GB, Gimenez-Roqueplo AP, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SP, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab. 2010;95:E373–83.

    Article  PubMed  Google Scholar 

  • Dong Q, Brucker-Davis F, Weintraub BD, Smallridge RC, Carr FE, Battey J, Spiegel AM, Shenker A. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the Gαq, Gα11, Gαs, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab. 1996;81:1134–40.

    CAS  PubMed  Google Scholar 

  • Ezzat S, Horvath E, Kovacs K, Smyth HS, Singer W, Asa SL. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol. 1995;6:125–34.

    Article  PubMed  Google Scholar 

  • Filopanti M, Ballaré E, Lania AG, Bondioni S, Verga U, Locatelli M, Zavanone LM, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A. Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. J Endocrinol Investig. 2004;27:937–42.

    Article  CAS  Google Scholar 

  • Fliers E, van Furth WR, Bisschop PH. Cure of a thyrotrophin (TSH)-secreting pituitary adenoma by medical therapy. Clin Endocrinol. 2012;77:788–90.

    Article  Google Scholar 

  • Foppiani L, Ruelle A, Cavazzani P, Del Monte P. TSH-secreting adenomas: rare pituitary tumors with multifaceted clinical and biological features. J Endocrinol Investig. 2007;30:603–9.

    Article  CAS  Google Scholar 

  • Friedman E, Adams EF, Höög A, Gejman PV, Carson E, Larsson C, De Marco L, Werner S, Fahlbusch R, Nordenskjöld M. Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. J Clin Endocrinol Metab. 1994;78:568–74.

    CAS  PubMed  Google Scholar 

  • Gancel A, Vuillermet P, Legrand A, Catus F, Thomas F, Kuhn JM. Effets of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol. 1994;40:421–8.

    Article  CAS  Google Scholar 

  • Gasparoni P, Rubello D, Persani L, Beck-Peccoz P. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma. Thyroid. 1998;8:181–3.

    Article  CAS  PubMed  Google Scholar 

  • Gatto F, Barbieri F, Castelletti L, Arvigo M, Pattarozzi A, Annunziata F, Saveanu A, Minuto F, Castellan L, Zona G, Florio T, Ferone D. In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5. Pituitary. 2011;14:141–7.

    Article  CAS  PubMed  Google Scholar 

  • Gatto F, Grasso LF, Nazzari E, Cuny T, Anania P, Di Somma C, Colao A, Zona G, Weryha G, Pivonello R, Ferone D. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: might somatostatin analogs have a role as first-line therapy? Pituitary. 2015;18:583–91.

    Article  CAS  PubMed  Google Scholar 

  • Gershengorn MC, Weintraub BD. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of “inappropriate secretion of TSH”. J Clin Invest. 1975;56:633–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors. Thyroid. 1998;8:9–14.

    Article  CAS  PubMed  Google Scholar 

  • Gurnell M, Visser TJ, Beck-Peccoz P, Chatterjee VK. Resistance to thyroid hormone. In: Jameson JL, DeGroot LJ, editors. Endocrinology adult and pediatric. 7th ed. Philadelphia: Elsevier Saundres; 2016. p. 1648–65.

    Chapter  Google Scholar 

  • Horiguchi K, Yamada M, Umezawa R, Satoh T, Hashimoto K, Tosaka M, Yamada S, Mori M. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment. Endocr J. 2007;54:371–8.

    Article  CAS  PubMed  Google Scholar 

  • Idiculla JM, Beckett G, Statham PF, Ironside JW, Atkin SL, Patrick AW. Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and a-subunit. Ann Clin Biochem. 2001;38:566–71.

    CAS  PubMed  Google Scholar 

  • Iskandar SB, Supit E, Jordan RM, Peiris AN. Thyrotropin-secreting pituitary tumor and Hashimoto’s disease: a novel association. South Med J. 2003;96:933–6.

    Article  PubMed  Google Scholar 

  • Kamoi K, Mitsuma T, Sato H, Yokoyama M, Washiyama K, Tanaka R, Arai O, Takasu N, Yamada T. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves’ disease in a middle-aged woman. Acta Endocrinol. 1985;110:373–82.

    CAS  PubMed  Google Scholar 

  • Kamoun M, d’Herbomez M, Lemaire C, Fayard A, Desailloud R, Huglo D, Wemeau JL. Coexistence of thyroid-stimulating hormone-secreting pituitary adenoma and Graves’ hyperthyroidism. Eur Thyroid J. 2014;3:60–4.

    Article  PubMed  Google Scholar 

  • Kienitz T, Quinkler M, Strasburger CJ, Ventz M. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol. 2007;157:39–46.

    Article  CAS  PubMed  Google Scholar 

  • Kirkman MA, Jaunmuktane Z, Brandner S, Khan AA, Powell M, Baldeweg SE. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence. World Neurosurg. 2014;82:1224–31.

    Article  PubMed  Google Scholar 

  • Kishida M, Otsuka F, Kataoka H, Yokota K, Oishi T, Yamauchi T, Doihara H, Tamiya T, Mimura Y, Ogura T, Makino H. Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma. Endocr J. 2000;47:731–8.

    Article  CAS  PubMed  Google Scholar 

  • Koulouri O, Gurnell M. How to interpret thyroid function tests. Clin Med (Lond). 2013;13:282–6.

    Article  Google Scholar 

  • Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013;27:745–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab. 1977;45:534–43.

    Article  CAS  PubMed  Google Scholar 

  • Kourides IA, Pekonen F, Weintraub BD. Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism. J Clin Endocrinol Metab. 1980;51:272–4.

    CAS  PubMed  Google Scholar 

  • Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab. 2000;85:1487–91.

    Article  CAS  PubMed  Google Scholar 

  • Langlois MF, Lamarche JB, Bellabarba D. Long-standing goiter and hypothyroidism: an unusual presentation of a TSH-secreting adenoma. Thyroid. 1996;6:329–35.

    Article  CAS  PubMed  Google Scholar 

  • Lee W, Cheung AS, Freilich R. TSH-secreting pituitary carcinoma with intrathecal drop metastase. Clin Endocrinol. 2012;76:604–6.

    Article  CAS  Google Scholar 

  • Lim EM, Bhagat CI, Walsh J. Asymptomatic thyrotropin-secreting pituitary microadenoma. Intern Med J. 2001;31:428–9.

    Article  CAS  PubMed  Google Scholar 

  • Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 1996;81:3086–90.

    Google Scholar 

  • Losa M, Magnani P, Mortini P, Persani L, Acerno S, Giugni E, Songini C, Fazio F, Beck-Peccoz P, Giovanelli M. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels. Eur J Nucl Med. 1997;24:728–31.

    CAS  PubMed  Google Scholar 

  • Losa M, Mortini P, Minelli R, Giovanelli M. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism. J Endocrinol Investig. 2006;29:555–9.

    Article  CAS  Google Scholar 

  • Lu C, Willingham MC, Furuya F, Cheng SY. Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyrois-stimulating hormone-secreting pituitary tumors. Endocrinology. 2008;149:3339–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma W, Ikeda H, Watabe N, Kanno M, Yoshimoto T. A plurihormonal TSH-producing pituitary tumor of monoclonal origin in a patient with hypothyroidism. Horm Res. 2003;59:257–61.

    CAS  PubMed  Google Scholar 

  • Malchiodi E, Profka E, Ferrante E, Sala E, Verrua E, Campi I, Lania AG, Arosio M, Locatelli M, Mortini P, Losa M, Motti E, Beck-Peccoz P, Spada A, Mantovani G. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab. 2014;99:2069–76.

    Article  CAS  PubMed  Google Scholar 

  • Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P. Different response to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol. 2005;62:176–81.

    Article  CAS  Google Scholar 

  • Mantovani G, Asteria C, Pellegrini C, Bosari S, Alberti L, Bondioni S, Peverelli E, Spada A, Beck-Peccoz P. HESX1 expression in human normal pituitaries and pituitary adenomas. Mol Cell Endocrinol. 2006;247:135–9.

    Article  CAS  PubMed  Google Scholar 

  • Mixson AJ, Friedman TC, Katz DA, Feuerstein IM, Taubenberger JK, Colandrea JM, Doppman JL, Oldfield EH, Weintraub BD. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab. 1993;76:529–33.

    CAS  PubMed  Google Scholar 

  • Mouslech Z, Somali M, Sakali AK, Savopoulos C, Mastorakos G, Hatzitolios AI. TSH-secreting pituitary adenomas treated by gamma knife radiosurgery: our case experience and a review of the literature. Hormones (Athens). 2016;15:122–8.

    Google Scholar 

  • Mulinda JR, Hasinski S, Rose LI. Successful therapy for a mixed thyrotropin-and prolactin-secreting pituitary macroadenoma with cabergoline. Endocr Pract. 1999;5:76–9.

    Article  CAS  PubMed  Google Scholar 

  • Nakayama Y, Jinguji S, Kumakura S, Nagasaki K, Natsumeda M, Yoneoka Y, Saito T, Fujii Y. Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report. Pituitary. 2012;15:110–5.

    Article  PubMed  Google Scholar 

  • Ness-Abramof R, Ishay A, Harel G, Sylvetzky N, Baron E, Greenman Y, Shimon I. TSH-secreting pituitary adenomas. Pituitary. 2007;10:307–10.

    Article  PubMed  Google Scholar 

  • Ohki M, Sato K, Tuchiya D, Sato S, Saito S, Kinjo T, Kayama T, Jokura H, Yoshimoto T. A case of TSH-secreting pituitary adenoma associated with an unruptured aneurysm: successful treatment by two-stage operation and gamma knife. No To Shinkei. 1999;51:895–9.

    CAS  PubMed  Google Scholar 

  • Ohta S, Nishizawa S, Oki Y, Namba H. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid: a case report and surgical strategy. Pituitary. 2001;4:271–4.

    Article  CAS  PubMed  Google Scholar 

  • Ónnestam L, Berinder K, Burman P, Dahlqvist P, Engström BE, Wahlberg J, Nyström HF. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab. 2013;98:626–35.

    Article  PubMed  CAS  Google Scholar 

  • Orme SM, Lamb JT, Nelson M, Belchetz PE. Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide. Postgrad Med J. 1991;67:466–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pasquini E, Faustini-Fustini M, Sciarretta V, Saggese D, Roncaroli F, Serra D, Frank G. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol. 2003;148:253–7.

    Article  CAS  PubMed  Google Scholar 

  • Pellegrini-Bouiller I, Morange-Ramos I, Barlier A, Gunz G, Enjalbert A, Jaquet P. Pit-1 gene expression in human pituitary adenomas. Horm Res. 1997;47:251–8.

    Article  CAS  PubMed  Google Scholar 

  • Pereira BD, Raimundo L, Mete O, Oliveira A, Portugal J, Asa SL. Monomorphous plurihormonal pituitary adenoma of pit-1 lineage in a giant adolescent with central hyperthyroidism. Endocr Pathol. 2016;27:25–33.

    Article  PubMed  Google Scholar 

  • Persani L, Preziati D, Matthews CH, Sartorio A, Chatterjee VK, Beck-Peccoz P. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clin Endocrinol. 1997;47:207–14.

    Article  CAS  Google Scholar 

  • Poggi M, Monti S, Pascucci C, Toscano V. A rare case of follicular thyroid carcinoma in a patient with thyrotropin-secreting pituitary adenoma. Am J Med Sci. 2009;337:462–5.

    Article  PubMed  Google Scholar 

  • Raappana A, Koivukangas J, Ebeling T, Pirilä T. Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab. 2010;95:4268–75.

    Article  CAS  PubMed  Google Scholar 

  • Rabbiosi S, Peroni E, Tronconi GM, Chiumello G, Losa M, Weber G. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs. Thyroid. 2012;22:1076–9.

    Article  CAS  PubMed  Google Scholar 

  • Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev. 1993;14:348–99.

    CAS  PubMed  Google Scholar 

  • Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P. Primary medical treatment of thyrotropin-secreting pituitary adenomas by first-generation somatostatin analogs: a case study of seven patients. Thyroid. 2015;25:877–82.

    Article  CAS  PubMed  Google Scholar 

  • Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 2000;288:154–7.

    Article  CAS  PubMed  Google Scholar 

  • Roelfsema F, Pereira AM, Keenan DM, Veldhuis JD, Romijn JA. Thyrotropin secretion by thyrotropinomas is characterized by increased pulse frequency, delayed diurnal rhythm, enhanced basal secretion, spikiness, and disorderliness. J Clin Endocrinol Metab. 2008;93: 4052–7.

    Article  CAS  PubMed  Google Scholar 

  • Safer JD, Colan SD, Fraser LM, Wondisford FE. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid. 2001;11:281–91.

    Article  CAS  PubMed  Google Scholar 

  • Sato S, Kanai N, Kanai H, Sugase T, Hanada M, Hayakawa T, Saito Y, Oonishi T, Oda Y, Miyagawa J. TSH-secreting fibrous pituitary adenoma showing calcification: a case report. No Shinkei Geka. 1995;23:259–63.

    CAS  PubMed  Google Scholar 

  • Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol. 2003;148:433–42.

    Article  CAS  PubMed  Google Scholar 

  • Song M, Wang H, Song L, Tian H, Ge Q, Li J, Zhu Y, Li J, Zhao R, Ji HL. Ectopic TSH-secreting pituitary tumor: a case report and review of prior cases. BMC Cancer. 2014;14:544–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Spada A, Bassetti M, Martino E, Giannattasio G, Beck-Peccoz P, Sartorio A, Vallar L, Baschieri L, Pinchera A, Faglia G. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine. J Endocrinol Investig. 1985;8:193–8.

    Article  CAS  Google Scholar 

  • Schoenmakers N, Moran C, Campi I, Agostini M, Bacon O, Rajanayagam O, Schwabe J, Bradbury S, Barrett T, Geoghegan F, Druce M, Beck-Peccoz P, O’ Toole A, Clark P, Bignell M, Lyons G, Halsall D, Gurnell M, Chatterjee K. A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 2014;99:E1381–6.

    Google Scholar 

  • Tagami T, Usui T, Shimatsu A, Beniko M, Yamamoto H, Moriyama K, Naruse M. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma. J Clin Endocrinol Metab. 2011;96:E948–52.

    Article  CAS  PubMed  Google Scholar 

  • Taylor TJ, Donlon SS, Bale AE, Smallridge RC, Francis TB, Christensen RS, Burma KD. Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1. Thyroid. 2000;10:1001–7.

    Article  CAS  PubMed  Google Scholar 

  • Teng X, Jin T, Brent GA, Wu A, Teng W, Shan Z. A patient with a thyrotropin-secreting microadenoma and resistance to thyroid hormone (P453T). J Clin Endocrinol Metab. 2015;100:2511–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Terzolo M, Orlandi F, Bassetti M, Medri G, Paccotti P, Cortelazzi D, Angeli A, Beck-Peccoz P. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin. J Clin Endocrinol Metab. 1991;72:415–21.

    Article  CAS  PubMed  Google Scholar 

  • Thompson LD, Seethala RR, Muller S. Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immuno-phenotypic study of 32 cases with a comprehensive review of the english literature. Head Neck Pathol. 2012;6:75–100.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tong A, Xia W, Qi F, Jin Z, Yang D, Zhang Z, Li F, Xing X, Lian X. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature. Thyroid. 2013;23:1172–7.

    Article  CAS  PubMed  Google Scholar 

  • Tritos NA, Eppakayala S, Swearingen B, Hedley-Whyte ET, Miller KK, Nachtigall LB, Grinspoon SK, Biller BM, Klibanski A. Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013;16:287–93.

    Article  CAS  PubMed  Google Scholar 

  • Ünlütürk U, Sriphrapradang C, Erdoğan MF, Emral R, Güldiken S, Refetoff S, Güllü S. Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature. J Clin Endocrinol Metab. 2013;98:2210–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Varsseveld NC, Bisschop PH, Biermasz NR, Pereira AM, Fliers E, Drent ML. A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas. Clin Endocrinol. 2014;80:395–402.

    Article  Google Scholar 

  • Wallace IR, Healy E, Cooke RS, Ellis PK, Harper R, Hunter SJ. TSH-secreting pituitary adenoma: benefits of pre-operative octreotide. Endocrinol Diabetes Metab Case Rep. 2015;2015:150007.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Q, Lu XJ, Sun J, Wang J, Huang CY, Wu ZF. Ectopic suprasellar thyrotropin-secreting pituitary adenoma: case report and literature review. World Neurosurg. 2016;95:617.e13–8.

    Article  Google Scholar 

  • Watanabe K, Kameya T, Yamauchi A, Yamamoto N, Kuwayama A, Takei I, Maruyama H, Saruta T. Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab. 1993;76:1025–30.

    CAS  PubMed  Google Scholar 

  • Webster J, Peters JR, John R, Smith J, Chan V, Hall R, Scanlon MF. Pituitary stone: two cases of densely calcified thyrotropin-secreting pituitary adenomas. Clin Endocrinol. 1994;40:137–43.

    Article  CAS  Google Scholar 

  • Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg. 2014;121: 1462–73.

    Article  PubMed  Google Scholar 

  • Yovos JG, Falko JM, O’Dorisio TM, Malarkey WB, Cataland S, Capen CC. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos. J Clin Endocrinol Metab. 1981;53:338–43.

    Article  CAS  PubMed  Google Scholar 

  • Zuniga S, Mendoza V, Espinoza IF, Zarate A, Mason M, Mercado M. A plurihormonal TSH-secreting pituitary microadenoma: report of a case with an atypical clinical presentation and transient response to bromocriptine therapy. Endocr Pathol. 1997;8:81–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Milan, Milan, Italy

    Paolo Beck-Peccoz

  2. Endocrinology and Metabolic Diseases Unit, Department of Clinical Sciences and Community Health, University of Milan, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy

    Claudia Giavoli & Giulia Rodari

  3. Department of Biomedical Sciences, Humanitas University and Endocrinology Unit, Humanitas Research Hospital, Rozzano, Italy

    Andrea Lania

Authors
  1. Paolo Beck-Peccoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Giavoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia Rodari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Lania
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Beck-Peccoz .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Biochemistry and Molecular Biology Department, University of Santiago de Compostela, Santiago de Compostela, Spain

    Felipe F. Casanueva

  2. Department of Medical Sciences, University of Torino, Torino, Italy

    Ezio Ghigo

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Beck-Peccoz, P., Giavoli, C., Rodari, G., Lania, A. (2018). Physiopathology, Diagnosis, and Treatment of Secondary Hyperthyroidism. In: Casanueva, F., Ghigo, E. (eds) Hypothalamic-Pituitary Diseases. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-44444-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44444-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44443-7

  • Online ISBN: 978-3-319-44444-4

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation